Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-045582
Filing Date
2004-03-19
Accepted
2004-03-19 15:26:38
Documents
13
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 VIROPHARMA, INCORPORATED -- FORM 10-K d10k.htm 10-K 1217928
3 SECOND AMENDED AND RESTATED SEVERANCE AGREEMENT dex1031.htm EX-10.31 55107
4 EXCHANGE AGREEMENT dex1032.htm EX-10.32 56598
5 OPTION AGREEMENT DATED NOVEMBER 25, 2003 dex1033.htm EX-10.33 207565
6 LETTER AGREEMENT DATED NOVEMBER 24, 2003 dex1034.htm EX-10.34 20452
7 EXCHANGE AGREEMENT dex1035.htm EX-10.35 54505
8 SCHEDULE OF RATIO OF EARNINGS TO FIXED INCOME dex121.htm EX-12.1 27928
9 CODE OF BUSINESS CONDUCT AND ETHICS dex14.htm EX-14 58750
10 LIST OF SUBSIDIARIES dex21.htm EX-21 1493
11 CONSENT OF KPMG LLP dex23.htm EX-23 2529
12 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 6399
13 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 6011
14 SECTION 906 CERTIFICATION OF CEO AND CFO dex321.htm EX-32.1 4065
  Complete submission text file 0001193125-04-045582.txt   1722408
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 04680044
SIC: 2834 Pharmaceutical Preparations